#Brussels #Belgium #Smartee #Clear Aligner #EAS Congress

Smartee Denti-Technology Presents at EAS Congress 2026

In an impressive showcase of clinical innovations, Smartee Denti-Technology, a leading player in clear aligner technology, presented its latest developments during the 7th Congress of the European Aligner Society (EAS) held from April 16 to 18, 2026, at the SQUARE – Brussels Convention Centre. The event, commemorating the society's 10th anniversary, attracted over 1,000 orthodontic professionals from 65 countries around the theme "Aligner Next Generation."

Focus on Aligner Science and Clinical Advances

The three-day congress featured a robust agenda centered on advancements in aligner science, clinical innovation, and the evolution of digital workflows. A significant emphasis was placed on the integration of artificial intelligence in treatment planning, 3D printing technologies, and the application of patient-specific biomechanics into contemporary orthodontic practices.

One of the highlights of Smartee’s contributions was a particular focus on mandibular repositioning techniques and early intervention strategies. On April 17, Dr. Te Wang from Shanghai TaiKang Dental Hospital delivered a significant lecture detailing a unique approach to managing severe jaw discrepancies using Smartee's S8-SGTB aligner. The session elaborated on how Smartee's system employs Mandibular Advancement Repositioning Technology (MART) to address complex skeletal Class II cases.

On the previous day, Dr. Vélez Lagunes led a comprehensive three-part session titled "Smartee Clear Aligner Innovative Approaches to Intercept and Correct Malocclusion in Growing Patients." This presentation highlighted the importance of early intervention to guide facial growth, consequently preventing the need for more invasive treatments in the future. Dr. Thomas Felkai then followed with clinical examples demonstrating how Smartee's S11 arch expander can effectively be integrated into orthodontic care for arch expansion needs.

The response from attendees was overwhelmingly positive, with many practitioners expressing eagerness to incorporate Smartee’s advanced technologies into their respective practices. Clinicians actively engaged with detailed inquiries regarding the biomechanics involved in mandibular advancement and the practical implementation of the S11 arch expanders, showcasing their keen interest in these innovations.

Expanding European Presence and Support Infrastructure

Recognizing Europe as one of the largest and rapidly growing markets for clear aligners, Smartee has continued to enhance its regional infrastructure. To bolster its presence in the continental market, the company inaugurated a manufacturing facility in Madrid, Spain, in 2024. This facility serves as a vital strategic hub for localized production, ensuring efficient delivery and service to European clinicians.

Further expanding its reach, in October 2025, Smartee established its UK subsidiary, alongside the European Orthodontic Clinical Support Center located in Stoke-on-Trent. This center is designed to provide crucial support services including treatment planning, case analysis, and technical assistance tailored to meet European clinical standards.

To ensure ongoing education aligns with local practices, Smartee collaborates closely with notable regional opinion leaders and educational professionals to continuously develop training programs that cater specifically to the evolving clinical needs of European orthodontists. These collaborative efforts seek to foster a community of knowledgeable professionals well-versed in the latest advancements in orthodontic treatment protocols.

The EAS Congress 2026 marked a pivotal moment for Smartee Denti-Technology, emphasizing not only its commitment to driving clinical innovation but also its dedication to enhancing its support infrastructure across Europe. As the demand for clear aligner treatments continues to surge, Smartee stands at the forefront, prepared to meet the professional needs of orthodontists and improving patient outcomes across the continent.